Creavo Medical Technologies Ltd is a UK-based, privately held medical technology company that has developed an innovative diagnostic platform based technology for use in elective and emergency clinical settings.
We have held three successful investment rounds since July 2015, raising more than £20 million, by demonstrating the strength of our strategy and leadership team. We’re backed by IP Group plc, a developer of intellectual property-based businesses,which has been an investor since our inception. The company has also attracted other investors, including Parkwalk Advisors Ltd and Puhua Capital Ltd, plus long-term support from the University of Leeds.
If you are interested in discussing investment opportunities, we’d like to hear from you.
Please send your investment enquiry via the following form
Timeline of Key Achievements
Company created as a spin out from the University of Leeds with initial £1.6m “seed funding”
60 60 clinical study completed at Leeds
£4.6m raised in Series A funding round
Company received ISO 13485
Creavo's research device receives CE mark
Start of 750 patient, multi-site effectiveness study in five major UK ED's
£13.4m raised in Series B funding round
Creavo's research device receives FDA 510(k) approval
Start of 720 patient, multi-site effectiveness study in five major US healthcare research facilities